Yujie Shi Selected Research

Yujie Shi Research Topics

Disease

21	Neoplasms (Cancer) 05/2024 - 06/2011
9	Breast Neoplasms (Breast Cancer) 05/2024 - 06/2011
5	Myocardial Infarction 12/2022 - 01/2015
3	Melanoma (Melanoma, Malignant) 05/2024 - 01/2018
3	Inflammation (Inflammations) 03/2024 - 04/2014
3	Carcinogenesis 01/2024 - 10/2018
3	Insulin Resistance 06/2023 - 10/2014
3	Infections 02/2023 - 01/2019
3	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2023 - 02/2014
2	Bites and Stings (Sting) 05/2024 - 10/2022
2	Pain (Aches) 03/2024 - 10/2020
2	COVID-19 07/2023 - 01/2023
2	Type 2 Diabetes Mellitus (MODY) 06/2023 - 01/2023
2	Hypoxia (Hypoxemia) 12/2022 - 01/2020
2	Mouth Neoplasms (Oral Cancer) 04/2022 - 01/2020
2	Coronary Artery Disease (Coronary Atherosclerosis) 08/2015 - 07/2015
1	Pulmonary Fibrosis (Fibrosing Alveolitis) 04/2024
1	Fibrosis (Cirrhosis) 04/2024
1	Hyperalgesia 03/2024
1	Urinary Bladder Neoplasms (Bladder Cancer) 02/2024
1	Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker) 01/2024
1	Neoplasm Metastasis (Metastasis) 01/2024
1	Birth Weight (Birth Weights) 12/2023
1	Fetal Growth Retardation (Intrauterine Growth Retardation) 12/2023
1	Triple Negative Breast Neoplasms 10/2023
1	Pneumonia (Pneumonitis) 01/2023
1	Malnutrition (Nutritional Deficiencies) 01/2023
1	Hypertension (High Blood Pressure) 01/2023
1	Myocardial Ischemia (Ischemic Heart Diseases) 12/2022
1	Castleman Disease (Castleman's Disease) 11/2022
1	Oral Leukoplakia 10/2022
1	Arthritis (Polyarthritis) 01/2022
1	Experimental Arthritis 01/2022
1	Leukoplakia 12/2021

Drug/Important Bio-Agent (IBA)

5	Proteins (Proteins, Gene)FDA Link 05/2024 - 06/2011
4	Polysaccharides (Glycans)IBA 05/2024 - 01/2019
3	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 04/2024 - 12/2022
3	CytokinesIBA 04/2024 - 10/2014
3	LipidsIBA 11/2021 - 04/2014
2	AntigensIBA 05/2024 - 11/2020
2	Vitamin D FDA LinkGeneric 12/2023 - 01/2023
2	SeleniumIBA 01/2023 - 04/2020
2	HydrogelsIBA 10/2022 - 01/2022
2	LigandsIBA 08/2021 - 01/2021
2	Long Noncoding RNAIBA 01/2021 - 01/2021
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 05/2024
1	Neuraminidase (Sialidase)IBA 05/2024
1	N-Acetylneuraminic Acid (Sialic Acid)IBA 05/2024
1	nintedanibIBA 04/2024
1	Tacrolimus (Prograf)FDA LinkGeneric 04/2024
1	Immunosuppressive Agents (Immunosuppressants)IBA 04/2024
1	Propofol (Diprivan)FDA LinkGeneric 03/2024
1	Remifentanil (Ultiva)FDA Link 03/2024
1	kartogeninIBA 03/2024
1	Small Interfering RNA (siRNA)IBA 03/2024
1	Carbonic Anhydrase IXIBA 03/2024
1	Drinking WaterIBA 02/2024
1	TrihalomethanesIBA 02/2024
1	DystrophinIBA 01/2024
1	25-hydroxyvitamin DIBA 12/2023
1	IntegrinsIBA 10/2023
1	AlbuminsIBA 07/2023
1	Oxidoreductases (Dehydrogenase)IBA 07/2023
1	BilirubinIBA 07/2023
1	CreatinineIBA 07/2023
1	Urea (Carbamide)FDA LinkGeneric 07/2023
1	SodiumIBA 06/2023
1	SaltsIBA 06/2023
1	Blood Glucose (Blood Sugar)IBA 06/2023
1	Enhancer of Zeste Homolog 2 ProteinIBA 02/2023
1	Histone MethyltransferasesIBA 02/2023
1	Ferritins (Ferritin)IBA 02/2023
1	IronIBA 01/2023
1	ferric ferrocyanide (Prussian blue)FDA Link 01/2023
1	Folic Acid (Vitamin M)FDA LinkGeneric 01/2023
1	MicronutrientsIBA 01/2023
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2023
1	NucleotidesIBA 12/2022
1	InflammasomesIBA 12/2022
1	daratumumabIBA 11/2022
1	ManganeseIBA 10/2022
1	Biomarkers (Surrogate Marker)IBA 04/2022
1	Histone Deacetylase InhibitorsIBA 01/2022
1	Transcription Factors (Transcription Factor)IBA 01/2022
1	CamptothecinIBA 01/2022
1	Hyaluronic Acid (Hyaluronan)IBA 01/2022
1	SolutionsIBA 01/2022
1	AcidsIBA 12/2021

Therapy/Procedure

11	Therapeutics 01/2024 - 01/2019
2	Photochemotherapy (Photodynamic Therapy) 12/2021 - 10/2021
2	Radiotherapy 01/2021 - 10/2020
2	Percutaneous Coronary Intervention 02/2018 - 01/2015
1	Oral Administration 01/2024
1	Injections 01/2022
1	Intralesional Injections 12/2021
1	Semiconductor Lasers 12/2021
1	Lasers (Laser) 12/2021
1	Laser Therapy (Surgery, Laser) 12/2021
1	Cryotherapy (Therapy, Cold) 12/2021
1	Punctures 12/2021